Clinical trial
Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever: Efficacy and Safety
NCT05273762 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever: Efficacy and Safety
- Lead sponsor
- Northwell Health
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 25, 2022
- Completion date
- July 25, 2027
- Enrollment
- 30 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.